Corcept Therapeutics Incorporated (CORT)

Check out top investors' recommendation for CORT
Last closing price (N/A)
(0.00%) ? 
Last closing price is the stock price upon last market close (date specified in parenthesis).
Return to date (1m/3m/6m/12m):
N/A ? 
Return to date is the stock return for the specified period of time.
Consensus price target (1m/3m/6m/12m):
Consensus price target is the average analyst price target for a specified period of time.
Buy/Sell Mix (1m/3m/6m/12m):
Buy/sell mix the percentage mix between Buy and Sell recommendations for a given company or a research firm. Hold recommendations are excluded.
Corcept Therapeutics Incorporated, a pharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of severe metabolic and psychiatric disorders in the United States. The company focuses on disorders that are associated with a steroid hormone called cortisol. It offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing’s syndrome, who have type 2 diabetes mellitus or glucose intolerance and have failed surgery or are not candidates for surgery. The company is also involved in an on-going Phase III study of mifepristone, the active ingredient in Korlym, for treatment of the psychotic features of psychotic depression. In addition, it discovers and develops three series of novel selective GR-II antagonists. The company has research and development agreements with Argenta Discovery Limited; Sygnature Discovery Limited; ICON Clinical Research, L.P.; and MedAvante, Inc. as well as has a patent license from Stanford University for developing mifepristone. Corcept Therapeutics Incorporated was founded in 1998 and is headquartered in Menlo Park, California.
An analyst is a professional research analyst or an Investor Wand user who issued a recommendation for a given company.
Research Firm
A Research Firm is a company that researches and rates stocks and publishes recommendations.
Signal is a recommendation issued by an analyst. Investor Wand considers two types of recommendations: BUY and SELL.
Signal Date
A signal date is a date when a BUY or SELL recommendation was issued for given security.
Initial Price
Initial Price is the first closing price for a specified company upon recommendation release. If the recommendation is issued in after-market hours, the Initial Price is the next day’s closing price (for a given symbol). In case of dividend distributions and stock splits, Initial Price is adjusted.
Price Target
A Price Target is an analyst’s projection of a company’s stock price by the end of the recommendation period. It represents the price at which the analyst would exit his or her existing position.
Closing Date
Closing Date is the expiration date of a recommendation. The validity timeframe of a professional analyst’s recommendation is 12 months. Investor Wand analysts can set their recommendation timeframe to one, three, six, or 12 months.
The return on a single open recommendation is calculated as the maximum of the current return (based on the latest closing price) and the target price return, if the symbol reached the target. The return on a single closed recommendation is calculated as the maximum of the return on the closing date (at the end of recommendation timeframe) and the target price return, if the stock hit the target price. The return is adjusted for one-time events (e.g., stock splits).
David Buck Shore Capital Buy   Jun 12, '18     30.00  Jun 12, '19  N/A 
Corey Davis Jefferies & Co. Buy   Apr 13, '18     32.00  Apr 13, '19  N/A 
David Buck Shore Capital Buy   Mar 08, '18     30.00  Mar 08, '19  N/A 
Charles Duncan Piper Jaffray Buy   Feb 05, '18     30.00  Feb 05, '19  N/A 
Charles Duncan Piper Jaffray Buy   Oct 11, '17     24.00  Oct 11, '18  N/A 
Charles Duncan Piper Jaffray Buy   Sep 08, '17     24.00  Sep 08, '18  N/A 
Charles Duncan Piper Jaffray Buy   May 15, '17     18.00  May 15, '18  N/A 
Charles Duncan Piper Jaffray Buy   Oct 19, '16     12.00  Oct 19, '17  N/A 
Charles Duncan Piper Jaffray Buy   Dec 22, '15   4.89    Dec 22, '16  N/A 
M Ian Somaiya Piper Jaffray Sell   Nov 07, '12   1.60    Nov 07, '13  -2.50% 
M Ian Somaiya Piper Jaffray Buy   Sep 12, '12   2.81  3.00  Sep 12, '13  -39.15% 
M Ian Somaiya Piper Jaffray Buy   Mar 09, '11   3.89  6.00  Mar 09, '12  2.83%